HIV/AIDSSee more about HIV/AIDS
- state & global data
- view as grid
- view as list
At noon ET on Monday, April 15, the Kaiser Family Foundation hosted a webcast (archived video below) to introduce EMPOWERED, a new campaign from Grammy Award-winning artist and HIV activist Alicia Keys and the Kaiser Family Foundation to reach women about HIV/AIDS. Ms. Keys was joined by White House Senior Advisor…
Alicia Keys in Washington, D.C., with Kaiser Family Foundation To Introduce Empowered Campaign To Reach Women in the U.S. About HIV/AIDS
White House Senior Advisor Valerie Jarrett, U.S. Rep. Barbara Lee Discuss Impact of HIV on Women. New Kaiser Report Shows Progress in Stemming New HIV Infections among Women in U.S., though Only a Quarter have Virus Suppressed with Treatment AIDS United Announces Community Grants Program to Support Efforts in Hard…
Recent guidelines are all recommending that HIV treatment be started at a higher CD4 count because of issues such as the ongoing damage caused by HIV itself, and prevention of transmission. Issues in long-term treatment, such as potential side effects, the development of resistance, the cost and sustainability of programmes in resource-poor settings, are some of the potential problems for such a strategy.
HIV programs represent the first successful large-scale chronic disease program in resource-limited settings in history.
Human resources have challenged efforts to scale-up HIV prevention, care and treatment programs in low- and middle-income countries.
Following on the heels of The Lancet themed issue on HIV prevention launched at AIDS 2008, The Lancet has commissioned a series on the global HIV epidemic among people who use drugs.
AIDS 2010: Integrating Sexual and Reproductive Health and Rights (SRHR) and HIV: Lessons from the Field
At the International Conference on Population and Development in Cairo in 1994, governments worldwide agreed that sexual and reproductive health and rights include HIV services.
AIDS 2010: Safety and Effectiveness of 1% Tenofovir Vaginal Microbicide Gel in South African Women: Results of the CAPRISA 004 Trial
An update of current state of microbicide development will be provided. Speakers will provide a state of microbicide development update, safety and efficacy data from CAPRISA 004 and implications of the CAPRISA 004 trial results for the microbicide and PrEP field.
Speakers include: Ward Cates (United States)President, Research,Â FHI Robert ClayExecutive Director, Department of HIV/AIDS, USAID AnthonyÂ Fauci (United States)Director, NIAD Â